Dai Hanren相关文献与解析，生知库 | 链接生命科学的每一步

Mucosal-Associated Invariant T Cells: Origins, Biological Functions, Diseases, and Therapeutic Targets

黏膜相关不变T细胞：起源、生物学功能、疾病和治疗靶点

Zhu, Cheng; Huai, Qian; Du, Yishan; Li, Xingyu; Zhang, Fumin; Zhang, Yongkang; Wu, Mengwei; Dai, Ying; Li, Xiaolei; Dai, Hanren; Wang, Hua

细胞生物学

Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages

FGF21 修饰的间充质干/基质细胞通过调节巨噬细胞极化来减轻酒精性肝损伤

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000410

Huai, Qian; Zhu, Cheng; Zhang, Xu; Dai, Hanren; Li, Xiaolei; Wang, Hua

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease

神经酰胺和鞘氨醇-1-磷酸在非酒精性脂肪性肝病中的作用和发病机制研究进展

期刊:International Journal of Biological Sciences

影响因子:10

doi:10.7150/ijbs.78525

Zhu, Cheng; Huai, Qian; Zhang, Xu; Dai, Hanren; Li, Xiaolei; Wang, Hua

脂肪肝

发表日期：2023

文献求助收藏

Development of immune-related cell-based machine learning for disease progression and prognosis of alcoholic liver disease

开发基于免疫相关细胞的机器学习方法用于酒精性肝病的疾病进展和预后

期刊:Clinical and Translational Medicine

影响因子:6.8

doi:10.1002/ctm2.1322

Zhang, Xu; Feng, Xuezhe; Huai, Qian; Zhu, Cheng; Sun, Yingyin; Li, Xiaolei; Dai, Hanren; Wang, Honglin; Wang, Hua

Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications

间充质基质/干细胞及其细胞外囊泡在肝脏疾病中的作用：免疫调节功能及临床应用研究进展

期刊:Cell and Bioscience

影响因子:6.2

doi:10.1186/s13578-023-01122-3

Huai, Qian; Zhu, Cheng; Zhang, Xu; Dai, Hanren; Li, Xiaolei; Wang, Hua

Optimal model establishment of whole-process management data for CAR-T therapy in China-how should this be done?

如何建立中国CAR-T疗法全过程数据管理的最佳模型？

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-021-00789-3

Li, Xiaolei; Dai, Hanren; Li, Xian; Li, Ping; Qian, Wenbin; Liang, Aibin; Han, Weidong

发表日期：2022

文献求助收藏

Exploring innate immunity in cancer immunotherapy: opportunities and challenges

探索先天免疫在癌症免疫疗法中的应用：机遇与挑战

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-021-00679-8

Li, Xiaolei; Dai, Hanren; Wang, Hua; Han, Weidong

Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy

低剂量HDACi可增强免疫疗法中巨噬细胞的抗肿瘤活性

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2021.1935668

Li, Xiaolei; Dai, Hanren; Wang, Hua

Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

更正：靶向CD19和CD22的双特异性CAR-T细胞用于治疗复发或难治性B细胞急性淋巴细胞白血病成人患者

期刊:Journal of Hematology & Oncology

影响因子:40.4

doi:10.1186/s13045-020-00878-2

Dai, Hanren; Wu, Zhiqiang; Jia, Hejin; Tong, Chuan; Guo, Yelei; Ti, Dongdong; Han, Xiao; Liu, Yang; Zhang, Wenying; Wang, Chunmeng; Zhang, Yajing; Chen, Meixia; Yang, Qingming; Wang, Yao; Han, Weidong

The role of TREM2 in sepsis

TREM2在脓毒症中的作用

Mucosal-Associated Invariant T Cells: Origins, Biological Functions, Diseases, and Therapeutic Targets

黏膜相关不变T细胞：起源、生物学功能、疾病和治疗靶点

Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages

FGF21 修饰的间充质干/基质细胞通过调节巨噬细胞极化来减轻酒精性肝损伤

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease

神经酰胺和鞘氨醇-1-磷酸在非酒精性脂肪性肝病中的作用和发病机制研究进展

Development of immune-related cell-based machine learning for disease progression and prognosis of alcoholic liver disease

开发基于免疫相关细胞的机器学习方法用于酒精性肝病的疾病进展和预后

Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications

间充质基质/干细胞及其细胞外囊泡在肝脏疾病中的作用：免疫调节功能及临床应用研究进展

Optimal model establishment of whole-process management data for CAR-T therapy in China-how should this be done?

如何建立中国CAR-T疗法全过程数据管理的最佳模型？

Exploring innate immunity in cancer immunotherapy: opportunities and challenges

探索先天免疫在癌症免疫疗法中的应用：机遇与挑战

Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy

低剂量HDACi可增强免疫疗法中巨噬细胞的抗肿瘤活性

Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

更正：靶向CD19和CD22的双特异性CAR-T细胞用于治疗复发或难治性B细胞急性淋巴细胞白血病成人患者